Valuation: Treace Medical Concepts, Inc.

Market Cap 280M 245M 226M 209M 396M 26.73B 403M 2.7B 1.06B 13.17B 1.05B 1.03B 45.27B P/E 2026 *
-4.8x
P/E 2027 * -5.17x
Enterprise Value 325M 285M 262M 242M 460M 31.03B 468M 3.14B 1.23B 15.28B 1.22B 1.19B 52.54B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.66x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day-7.30%
1 week+2.61%
Current month+8.54%
1 month+10.49%
3 months+138.67%
6 months+48.97%
Current year+76.33%
1 week 4.13
Extreme 4.1317
4.7
1 month 3.76
Extreme 3.755
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
25.22
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 64 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
-7.30%+2.61%-28.00%-81.11% 280M
+0.05%-0.15%+33.69%-1.01% 12.51B
-2.70%-7.53%+55.82%+31.36% 5.87B
+2.16%-0.14%+10.89%+13.56% 5.87B
+1.59%-1.92% - - 4.29B
+3.82%+5.25%-30.55%+12.58% 4.26B
+1.84%-2.18%-24.97%-28.54% 3.83B
+2.48%+3.12%+11.49%+272.46% 1.94B
-5.73%-5.23%-7.39%-59.79% 1.89B
-0.98%+0.83%+55.23%-4.57% 1.56B
Average -0.48%+0.11%+8.47%+17.22% 4.23B
Weighted average by Cap. +0.43%-0.70%+17.72%+15.29%

Financials

2026 *2027 *
Net sales 206M 180M 166M 154M 292M 19.67B 297M 1.99B 781M 9.69B 774M 758M 33.32B 222M 194M 179M 165M 314M 21.15B 319M 2.14B 840M 10.42B 833M 815M 35.83B
Net income -58.31M -51M -47.04M -43.45M -82.44M -5.56B -83.83M -562M -221M -2.74B -219M -214M -9.42B -54.66M -47.81M -44.1M -40.73M -77.28M -5.21B -78.58M -527M -207M -2.57B -205M -201M -8.83B
Net Debt 45.05M 39.41M 36.35M 33.57M 63.7M 4.3B 64.77M 434M 171M 2.12B 169M 165M 7.28B 88.04M 77.01M 71.03M 65.61M 124M 8.4B 127M 849M 333M 4.14B 331M 323M 14.22B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-10 US$4.320 -7.30% 431,318
26-07-09 US$4.660 +8.88% 475,518
26-07-08 US$4.280 -2.95% 480,749
26-07-07 US$4.410 -3.29% 624,865
26-07-06 US$4.560 +8.31% 662,392
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.320USD
Average target price
4.000USD
Spread / Average Target
-7.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock